Deadline: June 14, 2021 International Carbohydrates & Cell Media Scientist

The Position


The position as International Carbohydrates & Cell Media Scientist (CCS) will carry the responsibility for activities supporting the further development of Pharmacosmos' Cryopreservation Business. This includes supporting customer implementation of Pentahibe as well as driving further media optimization in collaboration with external collaborators.

The role requires a scientific background preferably combined with a business perspective.

The CCS will be part of the Carbohydrate Sales and Marketing team and report directly to the International Sales & Business Director.

Responsibilities


Develop, support and contribute to the commercialization of Pharmacosmos’ Cryopreservation Business

  • Engage in technical and scientific dialogue with clients, partners and stakeholders in the Cell-therapy and Biobanking areas. This includes support generation of new leads, technical support for customer engagement, as well as dialog with existing customers.
  • Develop Pharmacosmos’ cryopreservation products incl. cryomedia optimization.
  • Responsible for engaging in discussions on protocols, experiment design and publications.
  • Identify new applications and product opportunities
  • Contribute to the IP matters

Secondary responsibilities: Contribute to Pharmacosmos’ overall Carbohydrate Business, including development of the carbohydrate derivative business.

Professional qualifications & experience


  • You must hold a scientific academic degree in Life Sciences, e.g. cell biology, biochemistry, pharmaceutical sciences or other relevant discipline. Master level (MSc) or above, combined with 3-5 years relevant experience or preferably a PhD within a relevant area and preferably +2 years relevant experience.
  • The ideal candidate has experience within stem cell culturing, differentiation and cryopreservation. Hereunder screening and testing of different ingredients for e.g. full complex media formulations.
  • Knowledge of the regulatory framework of therapeutic cell products and medical devices is an advantage.

Personal Competencies


  • Strong scientific and analytical skills
  • Open-minded and a good communicator by nature
  • Strong sense of accountability, who delivers on agreements in a timely manner
  • Self-driven, systematic and with attention to detail
  • Strong interpersonal skills – robust with natural authority, easy going
  • Pragmatic and operational
  • Effective, transparent and open communication
  • Fluency in spoken and written English

Travel


Up to 40 days a year. The rest of the time is spent at the office in Holbæk.

The application


Please apply using the link in the blue box on the top right of this page.

Due to the GDPR regulation we do not accept applications by e-mail.

We are doing in June and expect employment in August

More information


You are welcome to contact Anne-Marie Ørkild, International Sales & Business Director, Carbohydrate for more information about the position on +45 2788 8766

About Pharmacosmos


Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in US, China, UK, Ireland, Germany, Sweden and Norway and its products are marketed in more than 80 countries around the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.

Our Carbohydrate Business Area


Pharmacosmos is the world leader in pharmaceutical quality carbohydrates, including a full range of dextran products. Our offerings include products that meet the US, European and Japanese pharmacopoeias.

Pharmacosmos further offers Dextran Ultra (very narrow distributions), Technical Quality Dextrans, Dextran Standards and GPC Standards. Pharmacosmos’ dextran products are manufactured for pharmaceutical and technical applications. Through advanced development, production technique and the highest standard of laboratory control combined with good and reliable service to the customers, Pharmacosmos has established a position as the leading manufacturer of pharmaceutical quality dextran products. Pharmacosmos recently completed a new synthesis facility enabling the company to manufacture a range of carbohydrate derivatives, with applications ranging from vaccines adjuvants to chromatographic applications.

Our Cryopreservation Business


The newest focus of Pharmacosmos’ carbohydrate business area is the application of carbohydrates in cryopreservation of cells and tissues. Cell therapies are anticipated to be the medical break-through of the century, but many supporting technologies must be improved in order for the field to realize its potential. The established standards for cryopreservation of cells are based on Dimethyl Sulfoxide (DMSO), which has a number of drawbacks in relation to side effects and handling. As a consequence, there is a growing demand from researchers and clinicians to eliminate or dramatically reduce the use of DMSO. Pharmacosmos has developed promising carbohydrate-based alternatives to DMSO with improved safety and at least equivalent efficacy. Pharmacosmos PentaHibe® (containing Pentaisomaltose®) is a safe and effective alternative to dimethyl sulfoxide (DMSO) for cryopreservation of cells. The objective is now to leverage Pharmacosmos’ existing cGMP production platform and to build supporting evidence and support for a new paradigm in cryopreservation. To learn more, visit www.pentahibe.com

Thank

Vi takker for din henvendelse og vender tilbage til dig hurtigst muligt

Pharmacosmos